Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,53 USD | +6,36% | +17,29% | -15,01% |
20/05 | PRIME MEDICINE, INC. : HC Wainwright past advies aan | ZM |
16/05 | PRIME MEDICINE, INC. : Citigroup verhoogt advies van Neutraal naar Kopen | ZM |
Omzet 2024 * | 4,44 mln. 4,09 mln. | Omzet 2025 * | 3,65 mln. 3,36 mln. | Marktkapitalisatie | 871 mln. 802 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -193 mln. -178 mln. | Nettowinst (verlies) 2025 * | -215 mln. -198 mln. | EV/omzet 2024 * | 179 x |
Nettoliquiditeiten 2024 * | 76,98 mln. 70,89 mln. | Nettoliquiditeiten 2025 * | 205 mln. 189 mln. | EV/omzet 2025 * | 182 x |
K/w-verhouding 2024 * |
-4,49
x | K/w-verhouding 2025 * |
-4,99
x | Werknemers | 234 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 73,52% |
Recentste transcriptie over Prime Medicine, Inc.
1 dag | +6,36% | ||
1 week | +17,29% | ||
Lopende maand | +53,05% | ||
1 maand | +66,96% | ||
3 maanden | -6,23% | ||
6 maanden | +8,35% | ||
Lopend jaar | -15,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-20 | |
Allan Reine
DFI | Director of Finance/CFO | 49 | 17/01 |
Chief Operating Officer | 52 | 01-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 01-12-21 | |
Robert Nelsen
BRD | Director/Board Member | 60 | 01-09-20 |
Michael Kelly
BRD | Director/Board Member | 67 | 01-11-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
4.71% | 2 M€ | -25,75% | ||
0.00% | 9 M€ | +11,21% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
20-05-24 | 7,53 | +6,36% | 750 326 |
17-05-24 | 7,08 | +0,57% | 610 441 |
16-05-24 | 7,04 | +4,14% | 847 000 |
15-05-24 | 6,76 | +1,50% | 537 933 |
14-05-24 | 6,66 | +3,74% | 842 888 |
uitgestelde koers Nasdaq, 20 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,01% | 819 mln. | |
+9,58% | 115 mld. | |
+12,41% | 106 mld. | |
-2,59% | 21,96 mld. | |
-12,38% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-3,35% | 18,08 mld. | |
-38,57% | 17,71 mld. | |
+7,51% | 14,32 mld. | |
+35,67% | 12,42 mld. |